Summary
We report a case of polymorphic reticulosis (PR) associated with pharyngeal replication of Epstein-Barr virus (EBV). A 78-year-old man with necrotic inflammatory granulations in the nasal cavities and ulcerative tissue of the tonsils was found to have PR after an initial diagnosis of lethal midline granuloma and was found to have high antibody titers to EBV. EBV-determined nuclear antigen (EBNA) was demonstrated in pharyngeal biopsy specimens by the anti-complement immunofluorescent technique, following which dual immunofluorescence staining, EBNA and T-cell antigen analysis were performed, using a wide variety of monoclonal antibodies. All of the EBNA-positive lymphocytes in the pharyngeal biopsy specimens were found to have exclusively T-cell antigens. This case strongly suggests that some of the cases of PR related to T-cell lymphomas may be closely associated with active EBV infection.
References
Eichel BS, Harrison EG, Devine KD, Scanlon PW, Brown HA (1966) Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg 112:597–605
Epstein MA, Achong BG (eds) (1979) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 1–22
Greenspan JS, Greenspan D, Lennette ET, Abrahams DJ, Conant MA, Petersen V, Freese UK (1985) Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. N Engl J Med 313: 1564–1571
Ishii Y, Yamanaka N, Ogawa K (1982) Nasal T cell lymphoma as a type of so-called “lethal midline granuloma”. Cancer 50: 2336–2344
Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Koizumi S, Osato T, Kobayashi I, Hamada I, Hirai K (1988) Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasakilike disease. Nature 333:455–457
Lippman SM, Grogan TM, Spier CM, Koopmann CF, Gall EP, Shimm DS, Durie BGM (1987) Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 59:936–939
Portnoy J, Ahronheim GA, Ghimbu F, Clencer B, Joncas JH (1984) Recovery of Epstein-Barr virus from genital ulcers. N Engl J Med 311:966–968
Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm AC, Anvert M, Pritchard J, Sloper C, Sieff C, Pincott J, Pachman L, Rich K, Cruzi F, Cornet JA, Collins R, Barnes N, Knight J, Sandstedt B, Klein G (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological and immunopathological studies. Cancer Res 41:4226–4236
Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell line. Int J Cancer 11:499–520
Robinson JE, Brown N, Andiman W, Halhy K, Francke U, Robert MF (1980) Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus. N Engl J Med 302: 1293–1297
Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225–1230
Sixbey JW, Lemon SM, Pagano JS (1986) A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet II: 1122–1124
Sixbey JW, Davis DS, Young LS, Hutt-Fletcher L, Tedder TF, Rikinson AB (1987) Human epithelial cell expression of an Epstein-Barr virus receptor. J Gen Virol 68: 805–811
Wolf H, Haus M, Wilmes E (1985) Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795–798
Yamanaka N, Kataura A, Sambe S, Minase T, Ishii Y (1985) Mid-facial T-cell lymphoma: characterization by monoclonal antibodies. Ann Otol Rhinol Laryngol 94:207–211
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Furukawa, M., Sakashita, H., Kimura, Y. et al. Association of Epstein-Barr virus with polymorphic reticulosis. Eur Arch Otorhinolaryngol 247, 261–263 (1990). https://doi.org/10.1007/BF00178999
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00178999